Tag: Retinal disease

Glaukos closes Avedro acquisition to expand corneal health franchise

pharmanewsdaily- December 15, 2019

Glaukos acquisition of Avedro : Glaukos Corporation, a California-based ophthalmic medical technology and pharmaceutical company, has completed its previously announced acquisition of Avedro. Based in ... Read More

Kodiak enrolls patients for retinal disease drug KSI-301’s phase 1 trial

pharmanewsdaily- September 2, 2018

Clinical trial news : Kodiak Sciences has completed enrollment of patients for a phase 1 safety and tolerability study to evaluate its retinal disease drug ... Read More